Visual field constriction as a side effect of GABA-mimetic antiepileptic agent;Alterations concentriques du champ visuel liees aux antiepileptiques GABA mimetiques

Journal Francais d'Ophtalmologie

Volumn 22, Issue 4, 1999, Pages 418-422

  Nordmann, J Ph ^a   Baulac, M ^b   Van Egroo, Ch ^c  

^a HÔPITAL TENON   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Antiepileptic agents; GABA; Pharmacology; Visual field

Indexed keywords

'ATRIUM'; 4 AMINOBUTYRIC ACID DERIVATIVE; ANTICONVULSIVE AGENT; PHENOBARBITAL; PROGABIDE; UNCLASSIFIED DRUG; VIGABATRIN; 4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; DRUG DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; DRUG ACTIVITY; DRUG MECHANISM; DRUG SAFETY; EPILEPSY; EYE TOXICITY; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; PERIMETRY; VISUAL FIELD DEFECT; COMPARATIVE STUDY; DRUG EFFECT; MIDDLE AGED; VISUAL FIELD;

ADULT; ANTICONVULSANTS; FEMALE; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PERIMETRY; PHENOBARBITAL; VIGABATRIN; VISUAL FIELDS;

EID: 0032912886     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Eke T, Talbot JF, Lawden MC. - Severe persistent visual field constriction associated with vigabatrin. BMJ, 1997 ; 314 : 180-1.
2. Harding GFA. - Severe persistent visual field constriction associated with vigabatrin : benefit-risk ratio must be calculated for individual patients. BMJ, 1998 ; 316 : 232-3.
3. Mackenzie R, Klistorner A. Asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ, 1998 ; 316 : 233.
4. Crofts K, Brennan R, Kearney P, O'Connor G. Vigabatrin-induced optic neuropathy. J Neurol, 1997 ; 244 : 666-7.
5. Vorwerk CA, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB. - Chronic low-cose glutamate is toxic to retinal ganglion cells. Invest Ophthalmol Vis Sci, 1996 ; 37 : 1618-24.
6. Sieghart W. Structure and pharmacology of g-aminobutyric acid receptor sub-types. Pharmacol Rev, 1995 ; 47 : 181-234.
7. Morselli PL, Llyod KG, Palminteri R. Progabide. In : Lewy R.H., Mattson R.H., Meldrum B.S., eds. Antiepileptic Drugs, 4th edition. New-York : Raven Press Ltd, 1995 ; 997-1009.
8. Paulus W, Schwartz G, Steinhoff BJ. The effect of anti-epileptic drugs on visual perception in patients with epilepsy. Brain, 1996; 119 : 539-49.
9. Remler BF, Leigh J, Osorio I, Tomsak RL. The characteristics and mechanisms of visual disturbance associated with anticonvulsivant therapy. Neurology, 1990 ; 40 : 791-6.
10. Baulac M, Nordmann JP, Lanoé Y. Severe visual-field constriction and side-effects of GABA-mimetic agents. The Lancet, 1998; 352 : 546.
11. Teil-Wilck K, Jokiel B, Zinser P, Heine F, Pfeiffer S, Wilck B, Guldin B, Ried S, Schmidt D. Afferent visual function after single dose application of -vinyl GABA. Neuro-ophthalmology, 1995 ; 15 : 305-10.